Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, ...

Brensocatib effectively reduces NSP activity in bronchiectasis patients, with greater reductions observed in the 25-mg dose group compared to the 10-mg group.

In patients with head and neck squamous cell carcinoma (HNSCC), low-dose CT achieved higher sensitivity than chest x-ray for detecting lung metastases and second primary lung cancer, but patients ...

Chest CT revealed persistent lung abnormalities in patients two years after COVID-19, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA). This ...

Two years after hospitalization for severe COVID-19 illness, more than a third of patients from the pandemic's early days had lingering pulmonary abnormalities on chest CT scans, according to a ...

In a recent study published in the Radiology journal, researchers performed the longitudinal evaluation of chest computerized tomography (CT) findings along with pulmonary function in coronavirus ...

Glenview, Illinois – On World Bronchiectasis Day (July 1), the American College of Chest Physicians (CHEST) is announcing the launch of Bridging Specialties ®: Timely Diagnosis for NTM Disease and ...

OXFORD, United Kingdom and HOUSTON, Aug. 26, 2025 /PRNewswire/ -- Optellum, a global leader in AI for lung health, today announced the world's first thorax CT foundation model built for precision lung ...